As more and more people around the world suffer from the flu, the NHL is doing what it can to help.
It is partnering with the Canadian Health Minister to provide a vaccine to all NHL players on the ice and in the arena for free, as well as a “treatment rash” of flu medication to players who have it.
While this could be seen as an effort to help people who need it, it could also be seen by some as a bid to promote the brand of pharmaceutical companies that have been around the league for decades.
“We are a big player in the pharmaceutical industry, and we have a lot of experience in this field, so it makes sense to have a partnership with one of the best in the world,” NHL deputy commissioner Bill Daly told reporters.
The NHL said that it will distribute a vaccine at the start of next season and a treatment rash at the end of the season.
The NHL has also set up a program in partnership with the International Federation of Sports Medicine, which will provide flu shots to players in the first three months of next year.
This will be the first time the NHL has offered a flu vaccine to players since it began offering it in 2010.
Although there has been a shortage of flu shots for some time, the league is working to fill the gap with a new vaccine.
Earlier this month, the hockey league issued an advisory saying it is not able to guarantee that the flu vaccine will be ready in time for next season.
It is expected to be ready by the end, but the timing has not yet been determined, said Dr. James LaPinta, a flu expert at the University of Toronto.
The National Institutes of Health said it expects the flu shot to be available by the time players are back in the lineup, but it may take longer to get it to the players.
According to the CDC, 1.5 million Americans get the flu each year, and nearly 100,000 die.
The majority of those people have been exposed to the virus before they got sick, so the chances of getting it again are slim, the CDC said.
In addition to helping people who are sick, the vaccine can help prevent other infections, including pneumonia.
The flu vaccine is also good for those who are underweight and have high blood pressure, but some people have had some complications from taking it.
Despite the flu pandemic, the number of flu vaccines distributed in the United States is actually lower than it was during the pandemic.
In December, the United Kingdom approved a five-year, $2 billion deal with GlaxoSmithKline to distribute the vaccine.
However, the deal is contingent on a new flu vaccine being approved by the Food and Drug Administration, which has yet to be approved.
If the flu outbreak continues, the numbers of flu vaccinations distributed to U.S. schools and hospitals could be even lower, LaPints said.